| dc.contributor.author | Diz-Küçükkaya, Reyhan | |
| dc.date.accessioned | 2015-09-16T12:43:19Z | |
| dc.date.available | 2015-09-16T12:43:19Z | |
| dc.date.issued | 2015 | |
| dc.identifier.citation | Diz-Küçükkaya R. Lupus anticoagulant, thrombosis, and death. Blood. 2015 May 28;125(22):3371-3372. doi: 10.1182/blood-2015-04-638320 | en_US |
| dc.identifier.issn | 0006-4971 | |
| dc.identifier.uri | http://www.bloodjournal.org/content/125/22/3371.full.pdf | en_US |
| dc.identifier.uri | https://hdl.handle.net/11446/793 | en_US |
| dc.description | İstanbul Bilim Üniversitesi, Tıp Fakültesi. | en_US |
| dc.description.abstract | A 32-year-old woman was referred to the hematology clinic after she was found to have persistently positive LA tests. In such a case, 3 distinct scenarios may prompt very different responses by the hematologist. In scenario 1, the patient has no symptoms or signs of antiphospholipid syndrome (APS) other than a positive LA. In scenario 2, she has livedo reticularis and thrombocytopenia that cannot be diagnosed as a definite APS. | en_US |
| dc.language.iso | eng | en_US |
| dc.publisher | American Society of Hematology | en_US |
| dc.identifier.doi | 10.1182/blood-2015-04-638320 | en_US |
| dc.rights | info:eu-repo/semantics/embargoedAccess | en_US |
| dc.title | Lupus anticoagulant, thrombosis, and death | en_US |
| dc.type | article | en_US |
| dc.relation.journal | Blood | en_US |
| dc.department | DBÜ, Tıp Fakültesi | en_US |
| dc.identifier.issue | 22 | en_US |
| dc.identifier.volume | 125 | |
| dc.identifier.startpage | 3371 | |
| dc.identifier.endpage | 3372 | |
| dc.contributor.authorID | TR116136 | en_US |
| dc.relation.publicationcategory | Belirsiz | en_US |
